Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4161459 | 0.87 | MAPT (0.39) | MAPTALOX15SLC22A6FAAHLMNA | |
| SCHEMBL912548 | 0.82 | MAPT (0.38) | MAPTALOX15SLC22A6LMNA | |
| SCHEMBL3605414 | 0.78 | MAPT (0.35) | MAPT | |
| SCHEMBL2352658 | 0.77 | MAPT (0.37) | MAPTFAAH | |
| SCHEMBL11045606 | 0.77 | MAPT (0.40) | MAPT | |
| SCHEMBL11865413 | 0.77 | MAPT (0.41) | MAPTALOX15SLC22A6FAAHLMNA | |
| SCHEMBL334795 | 0.77 | MAPT (0.44) | MAPTTSHRFAAH | |
| SCHEMBL28889016 | 0.76 | MAPT (0.42) | MAPTTSHRFAAHLMNASMN1; SMN2 | |
| SCHEMBL4666972 | 0.76 | MAPT (0.49) | MAPTTSHRLMNASMN1; SMN2 | |
| SCHEMBL2229574 | 0.76 | SMN1; SMN2 (0.43) | MAPTALOX15TSHRSLC22A6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1527039-B1 | PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES | BASELL POLIOLEFINE SRL (IT) | 2008-12-24 | — | — | EP | disclosed |
| US-7465821-B2 | Process for preparing alkylidene-substituted-1, 4-dions derivatives | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2008-12-16 | — | — | US | disclosed |
| US-7399879-B2 | Process for preparing alkylidene-substituted-1,4-dions derivatives | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2008-07-15 | — | — | US | disclosed |
| US-20050113599-A1 | Process for preparing alkylidene-substituted -1, 4-dions derivatives | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2005-05-26 | — | — | US | disclosed |
| EP-1527040-A1 | PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES | Basel Poliolefine Italia SpA (IT) | 2005-05-04 | — | — | EP | disclosed |
| EP-1527039-A1 | PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES | Basell Poliolefine Italia S.P.A. (IT) | 2005-05-04 | — | — | EP | disclosed |
| US-20050080290-A1 | Process for preparing alkylidene-substituted-1, 4-dions derivatives | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2005-04-14 | — | — | US | disclosed |
| WO-2004014838-A1 | PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2004-02-19 | — | — | WO | disclosed |
| WO-2004014839-A1 | PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES | BASEL POLIOLEFINE ITALIA S.P.A. (IT) | 2004-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113599-A1 | Process for preparing alkylidene-substituted -1, 4-dions derivatives | KCNJ4, NR3C2, NR4A2 | MAPT 4392/4885ALOX15 2434/4885TSHR 1192/4885 |
| US-20050080290-A1 | Process for preparing alkylidene-substituted-1, 4-dions derivatives | RTN4, NR4A2, NR3C2 | MAPT 4481/4885ALOX15 2015/4885TSHR 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.